Literature DB >> 14720217

Phospholipase D2 modulates agonist-induced mu-opioid receptor desensitization and resensitization.

Thomas Koch1, Lars-Ove Brandenburg, Yingjian Liang, Stefan Schulz, Andrea Beyer, Helmut Schröder, Volker Höllt.   

Abstract

Receptor phosphorylation, arrestin binding, uncoupling from G protein and subsequent endocytosis have been implicated in G protein-coupled receptor desensitization after chronic agonist exposure. In search of proteins regulating the mu-opioid receptor endocytosis, we have recently established that activation of phospholipase D (PLD)2 is required for agonist-induced mu-opioid receptor endocytosis. In this study, we determined the effect of PLD2 activity on the desensitization and resensitization rate of the mu-opioid receptor. We clearly demonstrated that inhibition of PLD2-mediated phosphatidic acid formation by alcohol (1-butanol or ethanol) or overexpression of a dominant negative mutant of PLD2 prevented agonist-mediated endocytosis and resulted in a faster desensitization rate of the mu-opioid receptor after chronic (D-Ala2, Me Phe4, Glyol5)enkephalin treatment in human embryonic kidney 293 cells. Moreover, inhibition of PLD2 activity led to an impairment of the resensitization rate of the mu-opioid receptor. In summary, our data strongly suggest that PLD2 is a modulator of agonist-induced endocytosis, desensitization and resensitization of the mu-opioid receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720217     DOI: 10.1046/j.1471-4159.2003.02189.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  28 in total

Review 1.  Mu-opioid receptor desensitization: is morphine different?

Authors:  Mark Connor; Peregrine B Osborne; MacDonald J Christie
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

2.  Phospholipase D2 is required for efficient endocytic recycling of transferrin receptors.

Authors:  David Padrón; Renee D Tall; Michael G Roth
Journal:  Mol Biol Cell       Date:  2005-11-16       Impact factor: 4.138

Review 3.  Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.

Authors:  Kirsten M Raehal; Cullen L Schmid; Chad E Groer; Laura M Bohn
Journal:  Pharmacol Rev       Date:  2011-08-26       Impact factor: 25.468

Review 4.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

5.  CRK2 Enhances Salt Tolerance by Regulating Callose Deposition in Connection with PLDα1.

Authors:  Kerri Hunter; Sachie Kimura; Anne Rokka; Huy Cuong Tran; Masatsugu Toyota; Jyrki P Kukkonen; Michael Wrzaczek
Journal:  Plant Physiol       Date:  2019-05-22       Impact factor: 8.340

Review 6.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 7.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

8.  Role of phospholipase D in parathyroid hormone type 1 receptor signaling and trafficking.

Authors:  José Luis Garrido; David Wheeler; Luis Leiva Vega; Peter A Friedman; Guillermo Romero
Journal:  Mol Endocrinol       Date:  2009-10-16

9.  Phosphatidic acid plays a regulatory role in clathrin-mediated endocytosis.

Authors:  Costin N Antonescu; Gaudenz Danuser; Sandra L Schmid
Journal:  Mol Biol Cell       Date:  2010-06-23       Impact factor: 4.138

Review 10.  β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia.

Authors:  Kirsten M Raehal; Laura M Bohn
Journal:  Handb Exp Pharmacol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.